Glam Health review
Two floors are published with B12 formulations named. Almost nothing else is.
The verdict
Glam Health publishes starting figures of $149 a month for compounded semaglutide and $175 for tirzepatide. Both are formulated with B12. No dose or coverage list is published.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- From
- From $149/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Glam Health sells both molecules by injection with B12. Each plan is described as including steady follow-up. Two floors are published.
Who writes the prescription, and what do they see?
The pages state a licensed provider reviews the tirzepatide plan. No clinician is named. The intake is not documented.
Steady follow-up is the phrase used and it is not defined. No cadence, no format, no charge is attached to it. A reader cannot tell what it costs or how often it happens.
What happens when the dose goes up?
Nothing is published about dose. No milligram figure appears beside either price. Starting at leaves the ceiling unstated as well as the floor's dose.
What the price includes
$149 and $175 are floors. Six months at them is $894 and $1,050 at best. A reader escalating pays an unpublished figure. Ask what the plan costs at a therapeutic dose before ordering.
What it claims, and what it cites
Both lines are compounded with B12. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.
Where it holds up, and where it does not
- Strength: Both molecules carry a published floor
- Strength: B12 formulation named on both lines
- Strength: A licensed provider review is stated
- Limitation: Both figures are a floor, not a rate
- Limitation: Steady follow-up is never defined
- Limitation: No milligram dose stated anywhere
- Limitation: No state coverage list is recorded
What the evidence says about this kind of treatment
The assessment above is about Glam Health. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader who will ask what the plan costs at their dose.
- Wrong for
- A reader who needs a settled monthly figure.
The evidence behind what Glam Health prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How Glam Health compares
| Seller | Who it suits | Go |
|---|---|---|
 Green Cap Health | Readers in Texas wanting the lowest published figures | See Green Cap Health → |
 Harbor | Readers who value a bundled plan and will ask what raises the floor | See Harbor → |
 Gala | Readers with insurance that may apply to Ozempic, or those ready to commit a year to compounded tirzepatide | See Gala → |
More GLP-1 telehealth sellers reviews: Genesis Lifestyle MedicineGide HealthGlowGOAL.MDGoodLife HealthHappy Care Meds
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Is $149 what I will pay?
- It is a starting figure. No dose is attached to it and no ceiling is published.
- What is steady follow-up?
- The phrase is used and not defined. No cadence, format or charge is attached to it.
- Which states are served?
- No coverage list is recorded. Ask before ordering.
- Is Glam Health expensive compared with other GLP-1 telehealth sellers?
- Glam Health publishes a starting figure of $149/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Glam Health below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.